2015
DOI: 10.18553/jmcp.2015.21.2.124
|View full text |Cite
|
Sign up to set email alerts
|

A Randomized Telephone Intervention Trial to Reduce Primary Medication Nonadherence

Abstract: BACKGROUND: Primary medication nonadherence (PMN), defined as patients not picking up an initial prescription, can limit the effectiveness of therapy for chronic conditions. Effective interventions to reduce PMN have not been widely studied or implemented.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
27
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 26 publications
(28 citation statements)
references
References 25 publications
1
27
0
Order By: Relevance
“…Although automated telephone reminders and letters have been shown to improve PNA to statins, 25 personal calls from patients' physicians did not result in further improve PNA. 26 Therefore, improvement in PNA may require tailored solutions that would be infeasible for use across all patients.…”
Section: Discussionmentioning
confidence: 99%
“…Although automated telephone reminders and letters have been shown to improve PNA to statins, 25 personal calls from patients' physicians did not result in further improve PNA. 26 Therefore, improvement in PNA may require tailored solutions that would be infeasible for use across all patients.…”
Section: Discussionmentioning
confidence: 99%
“…40 Real-time monitoring of pharmacy claims data could be used to intervene upon people who are no longer filling their ARV drug prescriptions and to offer adherence and other support. 41 …”
Section: Discussionmentioning
confidence: 99%
“…Estimates for rates of primary medication nonadherence (PMN) range from single digits to nearly 25% (Cheetham et al, 2013;Fischer et al, 2011;Fischer et al, 2014;Fischer et al, 2015;Jackson et al, 2014;Raebel et al, 2012;Shin et al, 2012). These estimates are for medications used to treat diseases including asthma, diabetes, hypertension, dyslipidemia and other conditions.…”
Section: B1 Primary Medication Nonadherencementioning
confidence: 99%
“…These estimates are for medications used to treat diseases including asthma, diabetes, hypertension, dyslipidemia and other conditions. Methods to evaluate PMN typically use e-prescribing data (Fischer et al, 2011;Fischer et al, 2014;Fischer et al, 2015;Jackson et al, 2014;Pharmacy Quality Alliance, 2013), but some studies have used prescribing and dispensing data from integrated care settings (Cheetham et al, 2013;Raebel et al, 2012;Shin et al, 2012). Estimates do not vary systematically over source of prescription data.…”
Section: B1 Primary Medication Nonadherencementioning
confidence: 99%
See 1 more Smart Citation